Viewing Study NCT05480293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-02-22 @ 3:56 PM
Study NCT ID: NCT05480293
Status: UNKNOWN
Last Update Posted: 2023-02-16
First Post: 2022-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD
Sponsor: Sinocelltech Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Wet Age-related Macular Degeneration View
Keywords: